← Open Payments lookup

MOISES ESQUENAZI: Open Payments

NPI 1659743797 · SOUTH MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,839 in 140 payments from 14 companies in 2025. Trend: 2023 $1,020 · 2024 $2,498 · 2025 $2,839

Food & beverage: $2,839
CompanyPaymentsAmount
Axsome Therapeutics, Inc.17$463
ABBVIE INC.35$445
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)19$366
Indivior Inc.11$299
Otsuka America Pharmaceutical, Inc.12$279
Takeda Pharmaceuticals U.S.A., Inc.9$223
Janssen Pharmaceuticals, Inc12$189
Vanda Pharmaceuticals Inc.7$185
E.R. Squibb & Sons, L.L.C.5$113
Almatica Pharma LLC3$72

Products named: Auvelity, VRAYLAR, CAPLYTA, SUBLOCADE, REXULTI, TRINTELLIX, INVEGA SUSTENNA, HETLIOZ.

Industry payments across FL — which companies pay providers there.